Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank27
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P27
Within normal range
Average
52.94%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 2024-100.00%
Q1 2024-89.32%
Q4 2023-91.18%
Q3 2023662.25%
Q2 2023253.59%
Q1 20230.00%